IP Verse

Millennium Pharmaceuticals, Inc. competitive analysis

Latest patents of Millennium Pharmaceuticals, Inc. opposed by its competitors

Explore Millennium Pharmaceuticals, Inc.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4403579
Dec 10, 2025Formulation For Anti-Alpha4Beta7 Antibody4
EP3329965
Mar 19, 2025Dosing Regimen Of Anti-Alpha4Beta7-Antibodies6
EP2318419
Oct 30, 2024Boronate Ester Compounds And Pharmaceutical Compositions Thereof3
EP3237004
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody1
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
EP2704742
Jul 12, 2017Formulation For Anti- 4 7 Antibody2
EP2704798
Jul 12, 2017Formulation For Anti- Alpha4Beta7 Antibody1
EP2730581
Apr 27, 2016Boronate Ester Compounds And Pharmaceutical Compositions Thereof1
EP1581629
Apr 1, 2015Methods For The Identification, Assessment, And Treatment Of Patients With Proteasome Inhibition Therapy1

Latest PTAB cases involving Millennium Pharmaceuticals, Inc.

Discover the latest PTAB cases involving Millennium Pharmaceuticals, Inc., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Millennium Pharmaceuticals, Inc. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MILLENNIUM PHARMACEUTICALS - 20 - -
ABEL & IMRAY17 - - -
FRESENIUS KABI SWISSBIOSIM2 - 2 -
TEVA PHARMACEUTICAL INDUSTRIES LTD2737 - -